NEW YORK (AP) - AMC is calling Saul Goodman for a spinoff of the network's drama series "Breaking Bad."
AMC and Sony Pictures Television on Wednesday confirmed the long-discussed spinoff, which will feature the popular supporting character from "Breaking Bad" in a one-hour prequel tentatively titled "Better Call Saul."
Played by Bob Odenkirk, Goodman is the sleazy New Mexico lawyer whose clients include "Breaking Bad" antiheroes Walter White and Jesse Pinkman, who manufacture crystal meth.
AMC said the new series would focus on Goodman before he crossed paths with those drug czars. The network provided no further details.
The 50-year-old Odenkirk's credits include "Saturday Night Live," "The Larry Sanders Show" and, paired with David Cross, HBO's "Mr. Show" sketch-comedy series.
"Breaking Bad" concludes its much-acclaimed five-season run on Sept. 29.
Anyway, as much as I like his character, the way it is played, I think he is the least believable character in the show. He is used for any deus ex machina to get whoever out of a bind, but largely untouched himself. After all the stuff that has gone down would a guy like him still even be in the country? He'd be too smart for that, but there he is, that jocular rock of support they can always go to..
anyway, I still love the show, and Saul.
_________________________ We are what we repeatedly do - Aristotle
Xplain's use of MacNews, AppleCentral and AppleExpo are not affiliated with Apple, Inc. MacTech is a registered trademark of Xplain Corporation. AppleCentral, MacNews, Xplain, "The journal of Apple technology", Apple Expo, Explain It, MacDev, MacDev-1, THINK Reference, NetProfessional, MacTech Central, MacTech Domains, MacForge, and the MacTutorMan are trademarks or service marks of Xplain Corp. Sprocket is a registered trademark of eSprocket Corp. Other trademarks and copyrights appearing in this printing or software remain the property of their respective holders.
All contents are Copyright 1984-2010 by Xplain Corporation. All rights reserved. Theme designed by Icreon.